Correspondencia
Ivermectina en COVID-19. ¿Argumentum ad ignorantiam?
Ivermectin in COVID-19. Argumentun ad ignorantiam?
Y. Carlosama-Rosero
Grupo Interdisciplinario de Investigación en Salud-Enfermedad, Universidad Cooperativa de Colombia, Pasto, Nariño, Colombia
Leído
13216
Vecesse ha leído el artículo
1664
Total PDF
11552
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 9 | 0 | 9 |
| 2025 5 | 162 | 3 | 165 |
| 2025 4 | 124 | 1 | 125 |
| 2025 3 | 97 | 1 | 98 |
| 2025 2 | 102 | 0 | 102 |
| 2025 1 | 76 | 1 | 77 |
| 2024 12 | 130 | 0 | 130 |
| 2024 11 | 102 | 1 | 103 |
| 2024 10 | 89 | 3 | 92 |
| 2024 9 | 90 | 6 | 96 |
| 2024 8 | 379 | 1 | 380 |
| 2024 7 | 112 | 1 | 113 |
| 2024 6 | 129 | 2 | 131 |
| 2024 5 | 108 | 4 | 112 |
| 2024 4 | 110 | 1 | 111 |
| 2024 3 | 85 | 0 | 85 |
| 2024 2 | 59 | 9 | 68 |
| 2024 1 | 92 | 7 | 99 |
| 2023 12 | 86 | 3 | 89 |
| 2023 11 | 138 | 12 | 150 |
| 2023 10 | 141 | 10 | 151 |
| 2023 9 | 170 | 14 | 184 |
| 2023 8 | 86 | 2 | 88 |
| 2023 7 | 100 | 7 | 107 |
| 2023 6 | 114 | 7 | 121 |
| 2023 5 | 102 | 12 | 114 |
| 2023 4 | 83 | 9 | 92 |
| 2023 3 | 142 | 11 | 153 |
| 2023 2 | 98 | 7 | 105 |
| 2022 1 | 133 | 17 | 150 |
| 2022 12 | 164 | 14 | 178 |
| 2022 11 | 145 | 20 | 165 |
| 2022 10 | 194 | 14 | 208 |
| 2022 9 | 191 | 26 | 217 |
| 2022 8 | 148 | 36 | 184 |
| 2022 7 | 135 | 20 | 155 |
| 2022 6 | 118 | 27 | 145 |
| 2022 5 | 115 | 27 | 142 |
| 2022 4 | 153 | 19 | 172 |
| 2022 3 | 193 | 37 | 230 |
| 2022 2 | 179 | 23 | 202 |
| 2021 1 | 346 | 26 | 372 |
| 2021 12 | 341 | 33 | 374 |
| 2021 11 | 166 | 18 | 184 |
| 2021 10 | 144 | 26 | 170 |
| 2021 9 | 159 | 27 | 186 |
| 2021 8 | 155 | 27 | 182 |
| 2021 7 | 140 | 22 | 162 |
| 2021 6 | 140 | 32 | 172 |
| 2021 5 | 138 | 27 | 165 |
| 2021 4 | 897 | 94 | 991 |
| 2021 3 | 344 | 59 | 403 |
| 2021 2 | 471 | 69 | 540 |
| 2020 1 | 962 | 101 | 1063 |
| 2020 12 | 361 | 67 | 428 |
| 2020 11 | 251 | 38 | 289 |
| 2020 10 | 350 | 60 | 410 |
| 2020 9 | 318 | 80 | 398 |
| 2020 8 | 184 | 86 | 270 |
| 2020 7 | 502 | 357 | 859 |
Mostrar todo
